Ivory, a brain health platform focused on early cognitive screening, has raised $1 million in fresh funding to deepen its product, clinical, and IP capabilities. The round saw participation from Draper Associates and SAGE Venture Fund, an AIF fund launched by Ministry of Social Justice and Empowerment (MoSJE) (selection partners for Startups) and managed by IFCI Venture, a subsidiary of IFCI Limited and SIDBI. Ivory said it is aiming to make cognitive screening accessible, trackable, and part of routine preventive care. With this capital, the Shark Tank India-featured startup plans to further strengthen its technology stack, expand clinical capabilities, and enhance its product offerings particularly in building scalable, evidence-based solutions that integrate seamlessly across both consumer and clinical workflows.

Rahul Krishnan, Co-founder & CPO, Ivory, said, “Preventive healthcare in India is at an inflection point, but cognitive health has largely remained outside this shift. Our focus at Ivory is to make brain health measurable and actionable, much like other key health biomarkers. This round allows us to deepen our clinical and product capabilities, while continuing to build a scalable, digital-first layer for cognitive screening across both consumers and healthcare systems.”

About Ivory

Ivory, a Bengaluru-based healthtech startup focused on early cognitive decline detection, has been founded in October 2024 by Issac John and Rahul Krishnan. Ivory has also been expanding its partnerships across the healthcare ecosystem. Most recently, the startup collaborated with Metropolis Healthcare, a multinational chain of diagnostic labs, to launch the TruHealth Mind & Body package, an integrated preventive health offering that combines pathology diagnostics with neuroscience-based cognitive assessments.